Literature DB >> 2019157

Complications associated with brachytherapy alone or with laser in lung cancer.

B Khanavkar1, P Stern, W Alberti, J A Nakhosteen.   

Abstract

Relatively little has been reported about destruction through brachytherapy of mucosa-perforating and extraluminary tumors with probable large vessel involvement causing major hemorrhagic or fistular complications. We report 12 patients subjected to laser and brachytherapy for centrally occluding lung cancer, whom we have periodically followed up from June 1986 until they died. Although all laser procedures were free from complications, necrotic cavitation in five cases, two of which were accompanied by large bronchoesophageal fistulas, and massive fatal hemoptysis occurred in six. Minor complications included radiation mucositis (two), noncritical mucosal scarring (two), and cough (four). Characteristics that will identify patients at risk of developing fatal hemoptysis and fistulas should be better defined by imaging and endoscopic techniques. In such cases, modifying the protocol or using alternative procedures should be considered. Minor complications, such as cough, can be avoided by using topical steroid therapy (eg, beclomethasone dipropionate).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019157     DOI: 10.1378/chest.99.5.1062

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Management of lung cancer.

Authors:  A Melville; A Eastwood
Journal:  Qual Health Care       Date:  1998-09

2.  The role of interventional pulmonary procedures in the management of post-obstructive pneumonia.

Authors:  Ravindra M Mehta; Michael Cutaia
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

3.  High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indications.

Authors:  P Barber; R Stout
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

Review 4.  Treatment of unresectable lung cancer with brachytherapy.

Authors:  C Aygun; J E Blum
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

5.  Quality of life survey and palliative care in lung cancer patients.

Authors:  L Zoganas; G Bablekos; M Maiwand; A Charalabopoulos; V Andronadi; A Batistatou; G Vergoulas; K Charalabopoulos
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

Review 6.  Malignant central airway obstruction.

Authors:  Lakshmi Mudambi; Russell Miller; George A Eapen
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 7.  Bronchoscopic palliation of primary lung cancer: single or multimodality therapy?

Authors:  R S Santos; Y Raftopoulos; R J Keenan; A Halal; R H Maley; R J Landreneau
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

8.  Endobronchial radiation therapy for obstructing malignancies: ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients.

Authors:  H N Macha; B Wahlers; C Reichle; D von Zwehl
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 9.  HDR endobronchial brachytherapy in palliative and combined radical treatment of lung cancer.

Authors:  Jacek Fijuth
Journal:  J Contemp Brachytherapy       Date:  2010-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.